Team

The biotechnology sector is a paradigm of the knowledge economy where Human capital is at the basis of the creation of a collective intangible stock: science, expertise, creativity and self-confidence. These elements are the combination of the contributions attributable to each of the collaborators, and therefore, a stock that can be accumulated and used.

At ORYZON we are convinced that this Human Capital thus created benefits:

• our company, which has the challenge of competition in this global sector
• the worker, who is both the creator and the recipient of this capital
• the society of our country, that gathers the competitiveness gains generated by a growing collectivity of highly-trained proffessionals.